國立高雄大學圖資館 |

登入

回首頁

COVID-19 in dermatology

紀錄類型:	書目-電子資源 : Monograph/item
正題名/作者:	COVID-19 in dermatologyedited by Hazel H. Oon, Chee Leok Goh.
其他作者:	Oon, Hazel Hwee Boon.
出版者:	Cham :Springer Nature Switzerland :2023.
面頁冊數:	x, 186 p. :illustrations (some col.), digital ;24 cm.
Contained By:	Springer Nature eBook
標題:	SkinDiseases.
電子資源:	https://doi.org/10.1007/978-3-031-45586-5
ISBN:	9783031455865$q(electronic bk.)

COVID-19 in dermatology
COVID-19 in dermatology[electronic resource] /edited by Hazel H. Oon, Chee Leok Goh. - Cham :Springer Nature Switzerland :2023. - x, 186 p. :illustrations (some col.), digital ;24 cm. - Updates in clinical dermatology,2523-8892. - Updates in clinical dermatology..

Chapter 1. The Science of COVID-19 Disease -- Chapter 2. Cutaneous Manifestations of COVID-19 -- Chapter 3. Cutaneous Reactions to COVID-19 mRNA Vaccines -- Chapter 4. Cutaneous Reactions to non mRNA COVID-19 vaccines -- Chapter 5. Evaluation of the Patient With a Coronavirus Disease (COVID-19) Vaccine Cutaneous Reaction -- Chapter 6. Personal Protective Equipment (PPE) related Occupational Dermatoses during COVID 19 -- Chapter 7. COVID-19 OUTBREAK RESPONSE IN DERMATOLOGY -- Chapter 8. Leveraging on teledermatology in the COVID-19 pandemic -- Chapter 9. COVID-19 Dermatology Registries and the Impact of COVID-19 on Dermatology Research -- Chapter 10. Impact of COVID-19 on dermatology medical education -- Chapter 11. Management of immunosuppressed dermatology patients during COVID-19 -- Chapter 12. Therapeutic considerations of COVID-19 on aesthetic dermatology, dermatosurgery and skin cancer -- Chapter 13. Psychological aspects, sychodermatology and vaccine hesitancy during the COVID-19 pandemic -- Chapter 14. Oral COVID-19 Antiviral Agents in Dermatology Outpatient Treatment -- Chapter 15. The Economic Impact of COVID-19 on Dermatology .

Since the first cases of an acute respiratory illness were reported, the pathogen SARS-coV-2 (severe acute respiratory syndrome coronavirus 2) and its disease, COVID-19 have disrupted the world and changed the course of medical history. Clinics were under lockdown and supplies of critical drugs such as biologics and meladinine were delayed. The prolonged impact of disease has taken its toll on patients, their careers, medical staff, research and medical education. Shortly after the first landmark studies of COVID-19 vaccine trial data were made known, global mass vaccination programs were underway. Vaccine technology has expanded beyond messenger RNA (mRNA) to include non-replicating viral vectors, inactivated virus, and protein subunits. Cutaneous manifestations of vaccine reactions, including non-mRNA and their morphological patterns, indications and contraindications, vaccine global access, equity, allocation of booster doses, emerging COVID variants and subvariants, waning vaccine and treatment efficacy are the issues that begged to be explored. New oral therapies are available for treatment of COVID-19 but they bring with them drug-drug interactions and potential side effects. This book is a compilation of a concerted effort by dermatologists across the globe to join hands against COVID-19. Each chapter has been written by experts in the field, with first-hand experience and synthesized literature to offer the most up-to-date coverage in the fast-paced, changing landscape of COVID-19 in dermatology. COVID-19 in Dermatology is a valuable resource for dermatologists, dermatology residents and medical students, and general practitioners.

ISBN: 9783031455865$q(electronic bk.)

Standard No.: 10.1007/978-3-031-45586-5doiSubjects--Topical Terms:

348783
Skin
--Diseases.

LC Class. No.: RL72

Dewey Class. No.: 616.5

COVID-19 in dermatology
LDR:03837nmm a2200337 a 4500 001 654138
003 DE-He213
005 20231127164149.0
006 m d
007 cr nn 008maaau
008 240426s2023 sz s 0 eng d
020 $a 9783031455865$q(electronic bk.)
020 $a 9783031455858$q(paper)
024 7 $a 10.1007/978-3-031-45586-5 $2 doi
035 $a 978-3-031-45586-5
040 $a GP $c GP
041 0 $a eng
050 4 $a RL72
072 7 $a MJK $2 bicssc
072 7 $a MED017000 $2 bisacsh
072 7 $a MJK $2 thema
082 0 4 $a 616.5 $2 23
090 $a RL72 $b .C873 2023
245 0 0 $a COVID-19 in dermatology $h [electronic resource] / $c edited by Hazel H. Oon, Chee Leok Goh.
260 $a Cham : $b Springer Nature Switzerland : $b Imprint: Springer, $c 2023.
300 $a x, 186 p. : $b illustrations (some col.), digital ; $c 24 cm.
490 1 $a Updates in clinical dermatology, $x 2523-8892
505 0 $a Chapter 1. The Science of COVID-19 Disease -- Chapter 2. Cutaneous Manifestations of COVID-19 -- Chapter 3. Cutaneous Reactions to COVID-19 mRNA Vaccines -- Chapter 4. Cutaneous Reactions to non mRNA COVID-19 vaccines -- Chapter 5. Evaluation of the Patient With a Coronavirus Disease (COVID-19) Vaccine Cutaneous Reaction -- Chapter 6. Personal Protective Equipment (PPE) related Occupational Dermatoses during COVID 19 -- Chapter 7. COVID-19 OUTBREAK RESPONSE IN DERMATOLOGY -- Chapter 8. Leveraging on teledermatology in the COVID-19 pandemic -- Chapter 9. COVID-19 Dermatology Registries and the Impact of COVID-19 on Dermatology Research -- Chapter 10. Impact of COVID-19 on dermatology medical education -- Chapter 11. Management of immunosuppressed dermatology patients during COVID-19 -- Chapter 12. Therapeutic considerations of COVID-19 on aesthetic dermatology, dermatosurgery and skin cancer -- Chapter 13. Psychological aspects, sychodermatology and vaccine hesitancy during the COVID-19 pandemic -- Chapter 14. Oral COVID-19 Antiviral Agents in Dermatology Outpatient Treatment -- Chapter 15. The Economic Impact of COVID-19 on Dermatology .
520 $a Since the first cases of an acute respiratory illness were reported, the pathogen SARS-coV-2 (severe acute respiratory syndrome coronavirus 2) and its disease, COVID-19 have disrupted the world and changed the course of medical history. Clinics were under lockdown and supplies of critical drugs such as biologics and meladinine were delayed. The prolonged impact of disease has taken its toll on patients, their careers, medical staff, research and medical education. Shortly after the first landmark studies of COVID-19 vaccine trial data were made known, global mass vaccination programs were underway. Vaccine technology has expanded beyond messenger RNA (mRNA) to include non-replicating viral vectors, inactivated virus, and protein subunits. Cutaneous manifestations of vaccine reactions, including non-mRNA and their morphological patterns, indications and contraindications, vaccine global access, equity, allocation of booster doses, emerging COVID variants and subvariants, waning vaccine and treatment efficacy are the issues that begged to be explored. New oral therapies are available for treatment of COVID-19 but they bring with them drug-drug interactions and potential side effects. This book is a compilation of a concerted effort by dermatologists across the globe to join hands against COVID-19. Each chapter has been written by experts in the field, with first-hand experience and synthesized literature to offer the most up-to-date coverage in the fast-paced, changing landscape of COVID-19 in dermatology. COVID-19 in Dermatology is a valuable resource for dermatologists, dermatology residents and medical students, and general practitioners.
650 0 $a Skin $x Diseases. $3 348783
650 0 $a COVID-19 (Disease) $3 877725
650 0 $a Dermatology. $3 274951
700 1 $a Oon, Hazel Hwee Boon. $3 964938
700 1 $a Goh, Chee Leok. $3 964939
710 2 $a SpringerLink (Online service) $3 273601
773 0 $t Springer Nature eBook
830 0 $a Updates in clinical dermatology. $3 810013
856 4 0 $u https://doi.org/10.1007/978-3-031-45586-5
950 $a Medicine (SpringerNature-11650)